Refine your search

Mechanisms of cancer and metabolic disease (Levonen Lab)´s Profile image

Mechanisms of cancer and metabolic disease (Levonen Lab)

Research group
01.01.2010 -
A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences

Leaders

Levonen Lab focuses on two major research topics: cancer and metabolic diseases.

In Professor Anna-Liisa Levonen’s research group, we explore the dual role of the NRF2 transcription factor in cancer, with a particular focus on lung cancer. Additionally, we investigate metabolic diseases, emphasizing NRF2’s role in metabolic regulation and the detrimental metabolic effects of environmental toxicant exposure.

News

  • New publication!

    Our new article in Redox Biology: Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells
    New publication!
  • New publication!

    Our new article in Current Opinion in Chemical Biology: Electrophilic metabolites targeting the KEAP1/NRF2 partnership
    New publication!
  • New publication!

    Our recent article published in Archives of Toxicology: Metabolic effects of nuclear receptor activation in vivo after 28‑day oral exposure to…
    New publication!
  • Levonen Lab as part of a new EU-funded project

    The European Union has granted 8 million euros in funding from the Horizon Europe Programme to an international research project (NEMESIS), which…
    Levonen Lab as part of a new EU-funded project

Projects

Keywords

Publications

126 items